Yanzhen Cheng
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Sodium-glucose cotransporter 2 inhibitors alleviate renal fibrosis in diabetic kidney disease by inhibiting Hmgcs2 and Btg2 in proximal tubular cells.
Journal: Journal of translational medicine
Published: December 10, 2024
Network analysis and experimental verification of Salvia miltiorrhiza Bunge-Reynoutria japonica Houtt. drug pair in the treatment of non-alcoholic fatty liver disease.
Journal: BMC complementary medicine and therapies
Published: April 17, 2024
LncRNA HOTAIR accelerates free fatty acid-induced inflammatory response in HepG2 cells by recruiting SRSF1 to stabilize MLXIPL mRNA.
Journal: Cytotechnology
Published: November 01, 2023
Glucagon-like peptide-1 attenuates diabetes-associated osteoporosis in ZDF rat, possibly through the RAGE pathway.
Journal: BMC musculoskeletal disorders
Published: October 29, 2021
Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway.
Journal: American journal of physiology. Endocrinology and metabolism
Published: September 28, 2020
Effect of Acid or Base Interventions on Bone Health: A Systematic Review, Meta-Analysis, and Meta-Regression.
Journal: Advances in nutrition (Bethesda, Md.)
Published: September 15, 2020
Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway.
Journal: Frontiers in pharmacology
Published: August 29, 2020
Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway.
Journal: Frontiers in pharmacology
Published: July 30, 2020
Interleukin-22 restored mitochondrial damage and impaired glucose-stimulated insulin secretion through down-regulation of uncoupling protein-2 in INS-1 cells.
Journal: Journal of biochemistry
Published: July 26, 2016
Last Updated: 09/26/2026